Shan, Bing
Chinese Academy of Sciences · Shanghai Institute of Organic Chemistry
7 papers on CoChatORCID 0000-0003-4178-3526
Most cited papers
- Verified
Protein Analysis by Shotgun/Bottom-up Proteomics
Zhang, Y., Fonslow, B. R., Shan, B., Baek, M.-C., & Yates, J. R. (2013) · Chemical Reviews
Advanced Proteomics Techniques and ApplicationsMass Spectrometry Techniques and Applications
Cited by 1,491
- Verified
GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand
Yang, L., Chang, C.-C., Sun, Z., Madsen, D., Zhu, H., Padkjær, S. B., Wu, X., Huang, T., Hultman, K., Paulsen, S. J., et al. (2017) · Nature Medicine
GDF15 and Related BiomarkersRegulation of Appetite and Obesity
Cited by 668
- Verified
Activation of Necroptosis in Multiple Sclerosis
Ofengeim, D., Ito, Y., Najafov, A., Zhang, Y., Shan, B., DeWitt, J. P., Ye, J., Zhang, X., Chang, A., Vakifahmetoglu-Norberg, H., et al. (2015) · Cell Reports
Cell death mechanisms and regulationMultiple Sclerosis Research Studies
Cited by 526
- Verified
TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging
Xu, D., Jin, T., Zhu, H., Chen, H., Ofengeim, D., Zou, C., Mifflin, L., Pan, L., Amin, P., Li, W., et al. (2018) · Cell
Cell death mechanisms and regulationAmyotrophic Lateral Sclerosis Research
Cited by 461
- Verified
Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis
Geng, J., Ito, Y., Shi, L., Amin, P., Chu, J., Ouchida, A. T., Mookhtiar, A. K., Zhao, H., Xu, D., Shan, B., et al. (2017) · Nature Communications
Cell death mechanisms and regulationNF-κB Signaling Pathways
Cited by 325
- Verified
Metformin activates chaperone-mediated autophagy and improves disease pathologies in an Alzheimer disease mouse model
Xu, X., Sun, Y., Cen, X., Shan, B., Zhao, Q., Xie, T., Wang, Z., Hou, T., Xue, Y., Zhang, M., et al. (2021) · Protein & Cell
Autophagy in Disease and TherapyAlzheimer's disease research and treatments
Cited by 171
- Verified
ARIH1 signaling promotes anti-tumor immunity by targeting PD-L1 for proteasomal degradation
Wu, Y., Zhang, C., Liu, X., He, Z., Shan, B., Zeng, Q., Zhao, Q., Zhu, H., Liao, H., Cen, X., et al. (2021) · Nature Communications
Cancer Immunotherapy and BiomarkersUbiquitin and proteasome pathways
Cited by 117
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free